|
1
|
Ohgaki H: Epidemiology of brain tumors.
Methods Mol Biol. 472:323–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Inoue T, Ogasawara K, Beppu T, Ogawa A and
Kabasawa H: Diffusion tensor imaging for preoperative evaluation of
tumor grade in gliomas. Clin Neurol Neurosurg. 107:174–180. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zonari P, Baraldi P and Crisi G:
Multimodal MRI in the characterization of glial neoplasms: The
combined role of singl-evoxel MR spectroscopy, diffusion imaging
and echo-planar perfusion imaging. Neuroradiology. 49:795–803.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takekawa Y and Sawada T: Vascular
endothelial growth factor and neovascularization in astrocytic
tumors. Pathol Int. 48:109–114. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdulrauf SI, Edvardsen K, Ho KL, Yang XY,
Rock JP and Rosenblum ML: Vascular endothelial growth factor
expression and vascular density as prognostic markers of survival
in patients with low-grade astrocytoma. J Neurosur. 88:513–520.
1998. View Article : Google Scholar
|
|
7
|
Brem S, Cotran R and Folkman J: Tumor
angiogenesis: A quantitative method for histologic grading. J Natl
Cancer Inst. 48:347–356. 1972.PubMed/NCBI
|
|
8
|
Maeda M, Itoh S, Kimura H, Iwasaki T,
Hayashi N, Yamamoto K, Ishii Y and Kubota T: Tumor vascularity in
the brain: Evaluation with dynamic susceptibility-contrast MR
imaging. Radiology. 189:233–238. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aronen HJ, Gazit IE, Louis DN, Buchbinder
BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF,
Hochberg FH, et al: Cerebral blood volume maps of gliomas:
Comparison with tumor grade and histologic findings. Radiology.
191:41–51. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sugahara T, Korogi Y, Kochi M, Ikushima I,
Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, et al: Correlation
of MR imaging-determined cerebral blood volume maps with histologic
and angiographic determination of vascularity of gliomas. AJR Am J
Roentgenol. 171:1479–1486. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knopp EA, Cha S, Johnson G, Mazumdar A,
Golfinos JG, Zagzag D, Miller DC, Kelly PJ and Kricheff II: Glial
neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging.
Radiology. 211:791–798. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tofts PS, Brix G, Buckley DL, Evelhoch JL,
Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, et
al: Estimating kinetic parameters from dynamic contrast-enhanced
T(1)-weighted MRI of a diffusable tracer: Standardized quantities
and symbols. J Magn Reson Imaging. 10:223–232. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang N, Zhang L, Qiu B, Meng L, Wang X
and Hou BL: Correlation of volume transfer coefficient Ktrans with
histopathologic grades of gliomas. J Magn Reson Imaging.
36:355–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia Z, Geng D, Xie T, Zhang J and Liu Y:
Quantitative analysis of neovascular permeability in glioma by
dynamic contrast-enhanced MR imaging. J Clin Neurosci. 19:820–823.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dujardin MI, Sourbron SP, Chaskis C,
Verellen D, Stadnik T, de Mey J and Luypaert R: Quantification of
cerebral tumour blood flow and permeability with T1-weighted
dynamic contrast enhanced MRI: A feasibility study. J Neuroradiol.
39:227–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sourbron SP and Buckley DL: Tracer kinetic
modelling in MRI: Estimating perfusion and capillary permeability.
Phys Med Biol. 57:R1–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnson G, Wetzel SG, Cha S, Babb J and
Tofts PS: Measuring blood volume and vascular transfer constant
from dynamic, T(2)*-weighted contrast-enhanced MRI. Magn Reson Med.
51:961–968. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rosen BR, Belliveau JW, Vevea JM and Brady
TJ: Perfusion imaging with NMR contrast agents. Magn Reson Med.
14:249–265. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murase K: Efficient method for calculating
kinetic parameters using T1-weighted dynamic contrast-enhanced
magnetic resonance imaging. Magn Reson Med. 51:858–862. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roberts HC, Roberts TP, Brasch RC and
Dillon WP: Quantitative measurement of microvascular permeability
in human brain tumors achieved using dynamic contrast-enhanced MR
imaging: Correlation with histologic grade. AJNR Am J Neuroradiol.
21:891–899. 2000.PubMed/NCBI
|
|
21
|
Daldrup H, Shames DM, Wendland M, Okuhata
Y, Link TM, Rosenau W, Lu Y and Brasch RC: Correlation of dynamic
contrast-enhanced MR imaging with histologic tumor grade:
Comparison of macromolecular and small-molecular contrast media.
AJR Am J Roentgenol. 171:941–949. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Provenzale JM, Wang GR, Brenner T,
Petrella JR and Sorensen AG: Comparison of permeability in
high-grade and low-grade brain tumors using dynamic susceptibility
contrast MR imaging. AJR Am J Roentgenol. 178:711–716. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roberts HC, Roberts TP, Ley S, Dillon WP
and Brasch RC: Quantitative estimation of microvascular
permeability in human brain tumors: Correlation of dynamic
Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad
Radiol. 9 (Suppl 1):S151–S155. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Falk A, Fahlström M, Rostrup E, Berntsson
S, Zetterling M, Morell A, Larsson HB, Smits A and Larsson EM:
Discrimination between glioma grades II and III in suspected
low-grade gliomas using dynamic contrast-enhanced and dynamic
susceptibility contrast perfusion MR imaging: A histogram analysis
approach. Neuroradiology. 56:1031–1038. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roy B, Awasthi R, Bindal A, Sahoo P, Kumar
R, Behari S, Ojha BK, Husain N, Pandey CM, Rathore RK and Gupta RK:
Comparative evaluation of 3-dimensional pseudocontinuous arterial
spin labeling with dynamic contrast-enhanced perfusion magnetic
resonance imaging in grading of human glioma. J Comput Assist
Tomogr. 37:321–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi HS, Kim AH, Ahn SS, Shin NY, Kim J
and Lee SK: Glioma grading capability: Comparisons among parameters
from dynamic contrast-enhanced MRI and ADC value on DWI. Korean J
Radiol. 14:487–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung SC, Yeom JA, Kim JH, Ryoo I, Kim SC,
Shin H, Lee AL, Yun TJ, Park CK, Sohn CH, et al: Glioma:
Application of histogram analysis of pharmacokinetic parameters
from T1-weighted dynamic contrast-enhanced MR imaging to tumor
grading. AJNR Am J Neuroradiol. 35:1103–1110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Filice S and Crisi G: Dynamic
contrast-enhanced perfusion MRI of high grade brain gliomas
obtained with arterial or venous waveform input function. J
Neuroimaging. 26:124–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bruger PC, Vogel FS, Green SB and Strike
TA: Glioblastoma multiforme and anaplastie astrocytoma: Pathologic
criteria and prognostic implications. Cancer. 565:1106–1111. 1985.
View Article : Google Scholar
|
|
30
|
Winkler F, Kienast Y, Fuhrmann M, Von
Baumgarten L, Burgold S, Mitteregger G, Kretzschmar H and Herms J:
Imaging glioma cell invasion in vivo reveals mechanisms of
dissemination and peritumoral angiogenesis. Glia. 57:1306–1315.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
van Dijke CF, Brasch RC, Roberts TP,
Weidner N, Mathur A, Shames DM, Mann JS, Demsar F, Lang P and
Schwickert HC: Mammary carcinoma model: Correlation of
macromolecular contrast-enhanced MR imaging characterizations of
tumor microvasculature and histologic capillary density. Radiology.
198:813–818. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schwickert HC, Stiskal M, Roberts TP, van
Dijke CF, Mann J, Mühler A, Shames DM, Demsar F, Disston A and
Brasch RC: Contrast-enhanced MR imaging assessment of tumor
capillary permeability: Effect of irradiation on delivery of
chemotherapy. Radiology. 198:893–898. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Taylor JS, Tofts PS, Port R, Evelhoch JL,
Knopp M, Reddick WE, Runge VM and Mayr N: MR imaging of tumor
microcirculation: Promise for the new millennium. J Magn Reson
Imaging. 10:903–907. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jensen RL, Mumert ML, Gillespie DL, Kinney
AY, Schabel MC and Salzman KL: Preoperative dynamic
contrast-enhanced MRI correlates with molecular markers of hypoxia
and vascularity in specific areas of intratumoral microenvironment
and is predictive of patient outcome. Neuro Oncol. 16:280–291.
2014. View Article : Google Scholar : PubMed/NCBI
|
